
Loading, please wait...

Loading, please wait...

Historically, total thyroidectomy has remained the non-negotiable standard for both hereditary and sporadic medullary thyroid cancer (sMTC). However, the therapeutic landscape is evolving as clinicians seek to balance oncologic safety with quality of life. This recent systematic review and meta-analysis evaluates whether thyroid lobectomy for sMTC offers comparable survival and recurrence outcomes in specific patient populations.
Researchers analyzed nine retrospective studies involving 1,371 patients to compare these surgical approaches. Notably, the study found no significant difference in five-year overall survival (RR, 1.02) or five-year mortality rates between the groups. Furthermore, biochemical cure rates remained similar at both the five-year mark and beyond. While total thyroidectomy showed an association with lower structural recurrence beyond five years, the early outcomes were comparable. Because the majority of tumors studied were smaller than 2 cm and lacked extrathyroidal extension, these findings suggest that less aggressive surgery may be sufficient for early-stage, unilateral disease.
A significant advantage of choosing a more conservative surgical route is the reduction in morbidity. Specifically, postoperative complications occurred more frequently in patients who underwent total thyroidectomy compared to those who received a lobectomy. Consequently, surgeons must weigh the potential for long-term recurrence against the immediate risks of permanent hypocalcemia or recurrent laryngeal nerve injury. Therefore, for carefully selected patients with low-risk sporadic tumors, the more limited surgical extent may preserve thyroid function without compromising long-term survival.
This meta-analysis provides evidence that the surgical management of sporadic medullary thyroid cancer is no longer one-size-fits-all. Although total thyroidectomy remains a powerful tool, thyroid lobectomy appears to be a safe alternative for patients with small, node-negative, unilateral tumors. Clinical teams should use these results to facilitate shared decision-making, ensuring that surgical plans are tailored to individual risk profiles.
No, this approach is typically reserved for selected patients with unilateral, sporadic tumors, generally smaller than 2 cm, without evidence of extrathyroidal extension or lymph node involvement.
Total thyroidectomy carries a higher risk of postoperative complications, including permanent hypoparathyroidism and damage to the recurrent laryngeal nerves, which can affect voice and calcium levels.
According to the meta-analysis, structural recurrence rates were similar at five years, though total thyroidectomy was associated with lower recurrence beyond the five-year period in some datasets.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A meta-analysis of 1,371 patients suggests that thyroid lobectomy may offer comparable oncologic outcomes to total thyroidectomy in selected sporadic MTC ca...
5 months ago

A Bayesian network meta-analysis evaluated non-surgical treatments for benign thyroid nodules, finding thermal ablation techniques like laser and radiofrequency ablation superior in nodule volume reduction, whereas levothyroxine showed the strongest TSH suppression without significant changes in FT3 or FT4.
Today

A retrospective study demonstrates that deep learning models using longitudinal digital breast tomosynthesis significantly enhance 5-year breast cancer risk prediction compared to single-timepoint imaging and clinical models.
Today

Researchers developed poly(trimethylene carbonate)-based polymersomes loaded with L-arginine for ROS-triggered nitric oxide release. This mild, stable nano-delivery system produces gas in response to hydrogen peroxide, offering a promising, targeted platform for cardiovascular, surgical, and oncological therapy.
Today

Researchers developed a Haversian-inspired composite scaffold that addresses delayed vascularization and wet-state mechanical deterioration in critical bone defect repair. By integrating spatially programmed calcium phosphate minerals and selective silica reinforcement, the design promotes vascularized bone repair.
Yesterday

A landmark study analyzing over 56,000 adult health records in Delhi-NCR reveals that hypertension and diabetes coexistence affects nearly 5% of adults. The prevalence doubles expected rates and rises sharply after age 40. Early integrated screening is essential to prevent microvascular and macrovascular complications.
Today